Video coaching from home: a new approach to help preterm babies catch up on motor skills

NCT ID NCT07725367

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial tests whether a family-centered early intervention program called the Homeostasis-Enrichment-Plasticity (HEP®) approach, delivered through weekly online sessions and home activities over 12 weeks, can improve motor development in preterm infants at risk for developmental delay. Researchers will compare infants receiving the HEP® program with those receiving usual care, measuring motor skills, sensory function, and parental well-being. The goal is to see if telerehabilitation can be an effective, accessible early intervention strategy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a family-centered early intervention program called the Homeostasis-Enrichment-Plasticity (HEP®) approach, delivered via weekly online sessions and home activities over 12 weeks
What this could lead to
If effective, this telerehabilitation program could offer a practical, home-based early intervention to improve motor development and reduce delays in preterm infants.
What could go wrong
This is a small, early-stage trial with only 32 infants, so results may not apply broadly. The intervention requires active parent participation, which may be challenging for some families.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEVELOPMENTAL DELAYS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Istanbul Medipol University, Kavacık Campus

    Istanbul, Istanbul, 34810, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.